WHO addresses Autism, Acetaminophen, and Vaccines
The World Health Association (WHO) is highlighting autism and neurodevelopmental disorders at the 4th UN High-Level Meeting on NCDs and mental health this Thursday, september 25th, emphasizing the need for increased understanding, care, and support for autistic individuals and their families. Globally, nearly 62 million people (1 in 127) live with autism spectrum disorder, a complex condition with diverse presentations. While awareness and diagnosis are improving, the exact causes remain unknown and likely involve multiple factors.
Addressing recent concerns, WHO clarifies that current scientific evidence does not establish a conclusive link between autism and acetaminophen (paracetamol) use during pregnancy. extensive research over the past decade, including large-scale studies, has not revealed a consistent association. WHO advises all pregnant women to continue following the guidance of their healthcare providers regarding medication use, particularly during the first trimester, and to exercise caution with any medicine.
Furthermore, WHO firmly reiterates the well-established scientific consensus: vaccines do not cause autism. Numerous large, high-quality studies from around the world have consistently demonstrated this. Original studies suggesting a link were flawed and have been discredited. independent experts advising WHO since 1999 have repeatedly confirmed the safety of vaccines – including those containing thiomersal or aluminum - and their lack of connection to autism or other developmental disorders.
WHO underscores the critical importance of adhering to recommended childhood immunization schedules, developed through a rigorous, evidence-based process involving global experts. These schedules, adopted by countries worldwide, have saved at least 154 million lives in the past 50 years and now protect against 30 infectious diseases. Delaying or disrupting these schedules, or altering them without evidence review, increases the risk of infection for both individuals and communities, particularly those most vulnerable.
WHO remains committed to advancing research and working with partners, including autistic-led organizations and those representing lived experience, to improve the lives of autistic people and their families, ensuring they receive dignified, evidence-based care free of stigma.
